The repeated use of high dose rate brachytherapy for locally recurrent lung cancer

Reports of Practical Oncology and Radiotherapy

Volumn 8, Issue 4, 2003, Pages 127-137

  Skowronek, Janusz ^a   Piotrowski, Tomasz ^a   Ramlau, Rodryg ^a   Cofta, Szczepan ^a   Świerkocki, Krzysztof ^a   Piorunek, Tomasz ^a   Młynarczyk, Witold ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

HDR Brachytherapy; Lung Cancer; Recurrence; Reirradiation

Indexed keywords

IRIDIUM 192;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BRACHYTHERAPY; CANCER PALLIATIVE THERAPY; CANCER REGRESSION; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DYSPNEA; FEMALE; HEMOPTYSIS; HIGH DOSE RATE BRACHYTHERAPY; HUMAN; LOCALLY RECURRENT LUNG CANCER; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PAIN; PROGNOSIS; RADIATION DOSE; RADIATION RESPONSE; RECURRENT CANCER; RETREATMENT; SURVIVAL TIME; TIME; TREATMENT INTERVAL;

EID: 0842312493     PISSN: 15071367     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1507-1367(03)71000-1     Document Type: Article

References (28)

1. Barber P, Stout R. High dose rate endobronchial brachytherapy for the treatment of lung cancer: current status and indications. Thorax 1996;51:345-7.
2. Delclos ME, Komaki R, Morice RC, Allen PK, Davis M, Garden A. Endobronchial brachytherapy with high-dose-rate remote afterloading for recurrent endobronchial lesions. Radiology 1996;201:279-82.
3. Stephens KE Jr, Wood DE. Bronchoscopic management of central airway obstruction. J Thorac Cardiovasc Surg 2000;119:289-96.
4. Sutedja G, Baris G, van Zadwijk N, Postmus PE. High-dose rate brachytherapy has a curative potential in patients with intraluminal squamous cell lung cancer. Respiration 1993;61:167-8.
5. Taulelle M, Chauvet B, Vincent P, Felix-Faure C, Buciarelli B, Garcia R, et al. High dose rate endobronchial brachytherapy: results and complications in 189 patients. Eur Respir J 1998;11:162-8.
6. Harms W, Schraube P, Becker H, Latz D, Herth F, Fritz P, et al. Effect and toxicity of endoluminal high-dose-rate (HDR) brachytherapy in centrally located tumors of the upper respiratory tract. Strahlenther Onkol 2000;176:60-6.
7. Hilaris BS, Mastoras DA. Contemporary brachytherapy approaches in non-small cell lung cancer. J Surg Oncol 1998;69:258-64.
8. Perol M, Caliandro R, Pommier P, Malet C, Montbarbon X, Carrie C, et al. Curative irradiation of limited endobronchial carcinomas with high-dose rate brachytherapy. Results of a pilot study. Chest 1997;111:1417-23.
9. Macha HN, Freitag L. The role of brachytherapy in the treatment and control of central bronchial carcinoma. Monaldi Arch Chest Dis 1996;51:325-8.
10. Gaspar LE. Brachytherapy in lung cancer. J Surg Oncol 1998;67:60-70.
11. Makarewicz R, Czechowicz W, Terlikiewicz J. Wstȩpna ocena skuteczności paliatywnej brachyterapii u chorych na niedrobnokomó rkowego raka plłuca. Nowotwory 1995;45:260-65 [in Polish].
12. Speiser BL. Brachytherapy in the treatment of thoracic tumors. Lung and esophageal. Hematol Oncol Clin North Am 1999;13:609-34.
13. Speiser BL, Spratling L. Remote afterloading brachytherapy for the local control of endobronchial carcinoma. Int J Radiat Oncol Biol Phys 1993;25:589-97.
14. Dosoretz DE, Katin MJ, Blitzer PH, Rubenstein JH, Galmarini DH, Garton GR, et al. Medically Inoperable Lung Carcinoma: The Role of Radiation Therapy. Semin Radiat Oncol 1996;6:98-104.
15. Langendijk H, de Jong J, Tjwa M, Muller M, ten Velde G, Aaronson N, et al. External irradiation versus external irradiation plus endobronchial brachytherapy in inoperable non-small cell lung cancer: a prospective randomized study. Radiother Oncol 2001;58:257-68.
16. Skowronek J, Adamska K, Zwierzchowski G, Cofta S, Świerkocki K., Piorunek T, et al. Treatment of Advanced Lung Cancer by External Beam Radiotherapy and High Dose Rate (HDR) Brachytherapy. Rep of Pract Oncol Radioth 2001;2:99-105.
17. Okamoto Y, Murakami M, Yoden E, Sasaki R, Okuno Y, Nakajima T, et al. Reirradiation for locally recurrent lung cancer previously treated with radiation therapy. Int J Radiat Oncol Biol Phys 2002;52:390-6.
18. Kelly JF, Delclos ME, Morice RC, Huaringa A, Allen PK, Komaki R. High-Dose-Rate endobronchial Brachytherapy effectively palliates symptoms due to airway tumors: the 10-year M.D.Anderson Cancer Center experience. Int J Radiat Oncol Biol Phys 2000;48:697-702.
19. Micke O, Prott FJ, Schäfer U, Pötter R, Willich N. Endoluminal HDR brachytherapy as a palliative treatment of patients with recurrent previously irradiated non-small cell lung carcinoma. Strahlenther Onkol 1995;171:554-59.
20. Gustafson G, Vincini F, Freedman L. High dose rate endobronchial brachytherapy in the management of primary and recurrent bronchogenic malignancies. Cancer 1994;75:2345-50.
21. Ornadel D, Duchesne G, Wall P, Ng A, Hetzel M, et al. Defining the roles of high dose rate endobronchial brachytherapy and laser resection for recurrent bronchial malignancy. Lung Cancer 1997;16:203-13.
22. Bedwinek J, Petty A, Bruton C. The use of high dose rate endobronchial brachytherapy to palliate symptomatic endobronchial recurrence of previously irradiated bronchogenic carcinoma. Int J Radiat Oncol Biol Phys 1991;22:23-30.
23. Gauwitz M, Ellerbroek N, Komaki R. High dose endobronchial irradiation in recurrent bronchogenic carcinoma. Int J Radiat Oncol Biol Phys 1992;23:397-400.
24. Huber RM, Fischer R, Hautmann H. Palliative endobronchial brachytherapy for central lung tumors. A prospective, randomized comparison of two fractionation schedules. Chest 1995;107:463-70.
25. Seagren SL, Harrell JH, Horn RA. High dose rate intraluminal irradiation in recurrent endobronchial carcinoma. Chest 1985;88:810-14.
26. Sutedja G, Baris G, Schaake-Koning C, van Zandwijk N. High dose rate brachytherapy in patients with local recurrences after radiotherapy of non-small cell lung cancer. Int J Radiat Oncol Biol Phys 1992;24:551-53.
27. Zajac AJ, Kohn ML, Heiser D, Peters JW. High-dose-rate intraluminal brachytherapy in the treatment of endobronchial malignancy. Radiology 1993;187:571-75.
28. Langendijk JA, Tjwa MKT, de Jong JMA, ten Velde GPM, Wouters EFM. Massive haemoptysis after radiotherapy in inoperable non-small cell lung carcinoma: is endobronchial brachytherapy really a risk factor? Radioth Oncol 1998;49:175-83.